THE FIRST EARLY RHEUMATOID ARTHRITIS, CERTOLIZUMAB PEGOL, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP STUDY: C-OPERA, IN PATIENTS FULFILLING THE 2010 ACR/EULAR CLASSIFICATION CRITERIA, DEMONSTRATES INHIBITION OF JOINT DAMAGE PROGRESSION